Contact Information Existing patients Contact the secretariat of the Department that is currently responsible for your care New patients For patiënts with localized, non-metastatic disease: Contact the Department of Oncological Surgery (+3216346831) or the Department of Orthopedic Surgery (+32163216338827) . For patients with advanced, metastatic disease contact the Department of General Medical Oncology (+3216346900). For pediatric patients contact the Department of Pediatric Oncology (+3216343972). Referrals For patiënts with localized, non-metastatic disease: Contact the Department of Oncological Surgery (+3216346831) or the Department of Orthopedic Surgery (+32163216338827) . For patients with advanced, metastatic disease contact the Department of General Medical Oncology (+3216346900). For pediatric patients contact the Department of Pediatric Oncology (+3216343972). Financial liason For patiënts with localized, non-metastatic disease: Contact the Department of Oncological Surgery (+3216346831) or the Department of Orthopedic Surgery (+32163216338827) . For patients with advanced, metastatic disease contact the Department of General Medical Oncology (+3216346900). For pediatric patients contact the Department of Pediatric Oncology (+3216343972). Designations and Memberships Our center has strong links with relevant organizations like EORTC, ASCO, AACR, SARC, CTOS and strong interaction with pharmaceutical companies running clinical trials. Sarcoma Faculty Medical Director Not applicable, the sarcoma activity is integrated in the clinical and research activities of the Leuven Cancer Institute, various clinical departments of UZ Leuven and various laboratories at KU Leuven. Not applicable Nurse Director Not applicable Administrative Director Not applicable Not applicable Physicians The questions above do not apply, as we are the biggest academic medical center in the county and all staff involved in sarcoma care also have non sarcoma-specific activities. We have more than 500 physicians working in our institution with representation of all disciplines relevant for state-of-the-art sarcoma treatment in house. Primary contacts for sarcoma patients or referrals as of July 2025: Prof. Patrick Schöffski, MD MPH, Head, Department of General Medical Oncology (systemic treatment of adult patients with sarcomas, including experimental therapies, among other activities) Prof. Daphne Hompes, MD PhD, Head, Department of Surgical Oncology (surgical treatment adult and pediatric patients with soft tissue tumors, among other activities) Dr. Friedl Sinnaeve, MD, Department of Orthopedic Surgery (orthopedic/surgical treatment of adult and pediatric patients with soft tissue and bone tumors, among other activities) Dr. Hazem Wafa, MD, Department of Orthopedic Surgery (orthopedic/surgical treatment of adlt and pediatric patients with soft tissue and bone tumors, among other activities) Dr. Marleen Renard, MD, Department Pediatric Oncology (systemic treatment of pediatric patients with sarcomas, including experimental therapies, among other activities) Dr. Melissa Christiaens, MD, Department or Radiotherapy/Oncology (radiotherapeutic treatment of adult and pediatric patients with sarcomas, among other activities) The selected colleagues listed here can provide further, more specific contacts in house for certain indications. Sarcoma Information New cases of sarcoma seen anually 251-500 Average number of sarcoma surgeries per year Over 100 Sarcoma clinical trials actively accruing patients in the past 12 months 10 Proton beam radiation therapy Yes Dedicated institutional sarcoma registry Yes Multi-disciplinary tumor board Yes Services Offered Telemedicine consultations No Sarcoma patient advocacy group Yes